Sign In

Login

Password

Forgot Password ? Sign Up

CD25 (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD25" in Polish language version.

Last modified:

Ref.Un. Ref.Website
Global rank Polish rank
1311nih.gov
5th place
7th place
119doi.org
2nd place
5th place

doi.org (Global: 2nd place; Polish: 5th place)

  • K. Sugamura, H. Asao, M. Kondo, N. Tanaka i inni. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.. „Annu Rev Immunol”. 14, s. 179-205, 1996. DOI: 10.1146/annurev.immunol.14.1.179. PMID: 8717512.
  • TR. Malek. The biology of interleukin-2.. „Annu Rev Immunol”. 26, s. 453-79, 2008. DOI: 10.1146/annurev.immunol.26.021607.090357. PMID: 18062768.
  • S. Létourneau, C. Krieg, G. Pantaleo, O. Boyman. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.. „J Allergy Clin Immunol”. 123 (4), s. 758-62, Apr 2009. DOI: 10.1016/j.jaci.2009.02.011. PMID: 19348914.
  • N. Pfender, R. Martin. Daclizumab (anti-CD25) in multiple sclerosis.. „Exp Neurol”. 262 Pt A, s. 44-51, Dec 2014. DOI: 10.1016/j.expneurol.2014.04.015. PMID: 24768797.
  • CA. Lindqvist, LH. Christiansson, B. Simonsson, G. Enblad i inni. T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.. „Immunology”. 131 (3), s. 371-6, Nov 2010. DOI: 10.1111/j.1365-2567.2010.03308.x. PMID: 20518821.
  • R. Cabrera, AI. Fitian, M. Ararat, Y. Xu i inni. Serum levels of soluble CD25 as a marker for hepatocellular carcinoma.. „Oncol Lett”. 4 (4), s. 840-846, Oct 2012. DOI: 10.3892/ol.2012.826. PMID: 23205111.
  • R. Gupta, A. Yadav, R. Misra, A. Aggarwal. Urinary sCD25 as a biomarker of lupus nephritis disease activity.. „Lupus”. 24 (3), s. 273-9, Mar 2015. DOI: 10.1177/0961203314555174. PMID: 25305215.
  • VV. Reddy, A. Myles, SS. Cheekatla, S. Singh i inni. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.. „Int J Rheum Dis”. 17 (3), s. 261-7, Mar 2014. DOI: 10.1111/1756-185X.12196. PMID: 24417800.
  • G. Matera, R. Puccio, A. Giancotti, A. Quirino i inni. Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study.. „Crit Care”. 17 (2), s. R64, 2013. DOI: 10.1186/cc12596. PMID: 23561467.

nih.gov (Global: 5th place; Polish: 7th place)

ncbi.nlm.nih.gov

  • K. Sugamura, H. Asao, M. Kondo, N. Tanaka i inni. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.. „Annu Rev Immunol”. 14, s. 179-205, 1996. DOI: 10.1146/annurev.immunol.14.1.179. PMID: 8717512.
  • IL2RA interleukin 2 receptor, alpha [Homo sapiens (human) - Gene - NCBI]. [dostęp 2015-03-25].
  • TR. Malek. The biology of interleukin-2.. „Annu Rev Immunol”. 26, s. 453-79, 2008. DOI: 10.1146/annurev.immunol.26.021607.090357. PMID: 18062768.
  • S. Létourneau, C. Krieg, G. Pantaleo, O. Boyman. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.. „J Allergy Clin Immunol”. 123 (4), s. 758-62, Apr 2009. DOI: 10.1016/j.jaci.2009.02.011. PMID: 19348914.
  • BC. Sheu, SM. Hsu, HN. Ho, HC. Lien i inni. A novel role of metalloproteinase in cancer-mediated immunosuppression.. „Cancer Res”. 61 (1), s. 237-42, Jan 2001. PMID: 11196168.
  • N. Pfender, R. Martin. Daclizumab (anti-CD25) in multiple sclerosis.. „Exp Neurol”. 262 Pt A, s. 44-51, Dec 2014. DOI: 10.1016/j.expneurol.2014.04.015. PMID: 24768797.
  • CA. Lindqvist, LH. Christiansson, B. Simonsson, G. Enblad i inni. T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.. „Immunology”. 131 (3), s. 371-6, Nov 2010. DOI: 10.1111/j.1365-2567.2010.03308.x. PMID: 20518821.
  • R. Cabrera, AI. Fitian, M. Ararat, Y. Xu i inni. Serum levels of soluble CD25 as a marker for hepatocellular carcinoma.. „Oncol Lett”. 4 (4), s. 840-846, Oct 2012. DOI: 10.3892/ol.2012.826. PMID: 23205111.
  • R. Gupta, A. Yadav, R. Misra, A. Aggarwal. Urinary sCD25 as a biomarker of lupus nephritis disease activity.. „Lupus”. 24 (3), s. 273-9, Mar 2015. DOI: 10.1177/0961203314555174. PMID: 25305215.
  • VV. Reddy, A. Myles, SS. Cheekatla, S. Singh i inni. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.. „Int J Rheum Dis”. 17 (3), s. 261-7, Mar 2014. DOI: 10.1111/1756-185X.12196. PMID: 24417800.
  • G. Matera, R. Puccio, A. Giancotti, A. Quirino i inni. Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study.. „Crit Care”. 17 (2), s. R64, 2013. DOI: 10.1186/cc12596. PMID: 23561467.